Skip to content

Relief from menopausal hot flashes night sweat and sleep disturbance with vidarikanda churna

EFFECT OF VIDARIKANDA CHURNA IN THE MANAGEMENT OF VASOMOTOR SYMPTOMS IN MENOPAUSAL SYNDROME AN OPEN LABEL SINGLE ARM INTERVENTIONAL CLINICAL STU - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085251
Enrollment
30
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

None listed

Sponsors

Dr Sukanya Busari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Women aged between 40-60 years . 2) Women with Vasomotor symptoms like hot flushes, sweating and sleep disturbance. 3) Perimenopausal women should meet one of the following criteria: - Women presenting with irregular menstrual period - Women presenting with history of amenorrhoea for a duration less than 12 months 4) Postmenopausal women should meet one of the following criteria: - Have a history of spontaneous amenorrhea for the last 12 months - Underwent Surgical Menopause

Exclusion criteria

Exclusion criteria: 1) Women already on Hormonal therapy or within 1 month of commencement of the study or an oestrogen implant within the past year. 2) Women who have had surgical menopause and have Oestrogen implant 3) Women with pelvic pathology like vault prolapse and malignancy of pelvic organ 4) Women with breast cancer or a history of breast cancer 5) Women aged below 40 years and above 60 years. 6) Women with Radiation Menopause.

Design outcomes

Primary

MeasureTime frame
Reduction in Vasomotor symptomsTimepoint: Reduction in Vasomotor symptoms

Secondary

MeasureTime frame
NilTimepoint:

Countries

India

Contacts

Public ContactDr Sukanya Busari

JSS Ayurvedic Medical College And Hospital Mysuru

vidya.dr@gmail.com9980760076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026